IL1B and inflammation: Together with the general lowering of the inflammation-inducing lipoproteins, among them the Lp(a) (90), an increased resolution of IL-1β-mediated vascular inflammation would allow an additional tool when attempting to reduce the risk of cardiovascular disease in people with an elevated level of Lp(a).